The study found that women with PCOS had higher PPARGC1A promoter methylation (36.5% vs. 26.3%) and lower mtDNA content (mtDNA/nDNA ratio) compared to controls, even after adjusting for BMI (P < 0.0001). Here, PPARGC1A is linked to polycystic ovary syndrome.